A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma

NCT00668499 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Sponsor withdrew support

Conditions

Mesothelioma

Interventions

DRUG: VEGF-Antisense Oligonucleotide , Pemetrexed, Cisplatin

Sponsor

University of Southern California

Collaborators

[object Object]